首页 | 本学科首页   官方微博 | 高级检索  
     


Hepatitis C infection in children and adolescents with end-stage renal disease
Authors:Zarela L. Molle  Noosha Baqi  David Gretch  Guillermo Hidalgo  Amir Tejani  S. S. Rabinowitz
Affiliation:(1) Division of Pediatric Gastroenterology and Nutrition, SUNY Health Science Center at Brooklyn, Brooklyn, New York, USA, US;(2) Division of Pediatric Nephrology, SUNY Health Science Center at Brooklyn, Brooklyn, New York, USA, US;(3) Department of Laboratory Medicine, University of Washington Medical Center, Seattle, Washington, USA, US;(4) Department of Pediatrics and Surgery, New York Medical College, Valhalla, New York, USA, US;(5) Department of Pediatric Gastroenterology and Nutrition, Long Island College Hospital, 339 Hicks Street, Brooklyn, NY 11201, USA e-mail: srabinmd@optonline.net Tel.: +1-718-7801025, Fax: +1-718-7802989, US
Abstract:
The prevalence of hepatitis C virus (HCV) infection and the risk factors associated with its transmission are described in a contemporary cohort of 55 children and adolescents with end-stage renal disease (ESRD). Thirty-seven patients were on dialysis or had been transplanted (ESRD) and 18 had chronic renal failure (CRF) but had not yet received dialysis. Seven (19%) tested positive for HCV by enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), or both. None of the children with CRF were infected. HCV infection was associated with length of time on dialysis, but not with age, gender, race, or units of blood transfused. These data corroborate earlier reports and confirm that children with ESRD continue to have a high prevalence of HCV. It is also shown for the first time that elevated transaminases should not be employed to predict HCV infection in this cohort, as all affected children had normal serum levels. Because of unique characteristics in this cohort, both ELISA and PCR are required to maximize HCV diagnostic sensitivity. Although HCV remains an important consideration in pediatric ESRD, the present study shows that recent advances in clinical practice have eliminated one of the major ways in which it was previously being transmitted. Received: 30 July 2001 / Revised: 2 January 2002 / Accepted: 4 January 2002
Keywords:  Hepatitis C  End-stage renal disease  Hemodialysis  Liver disease
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号